Phase 3
Completed N=502
A Long-term Safety Study of Once-daily Travatan
Glaucoma, Open-angle · Hypertension
Source: ClinicalTrials.gov NCT00051168 ↗
Enrolled (actual)
502
Serious AEs
19.7%
Results posted
Apr 2010
Primary outcomePrimary: Mean Intraocular Pressure — 16.5 millimeters mercury (mm Hg)
Summary
Long term safety study of TRAVATAN in patients with Open-angle glaucoma or ocular hypertension.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Intraocular Pressure |
16.5 | — |
Eligibility Criteria
Adult patients of any race and either sex with chronic angle-closure glaucoma.
Data sourced from ClinicalTrials.gov (NCT00051168). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.